Skip to main content

Table 1 Characteristics of patients with OCCC (N = 171)

From: Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma

Characteristic

N (%)

Age (years)

 

Median (range)

55.3 (32 − 80)

<55

79 (46.2)

≥55

92 (54.1)

FIGO stage

 

I

111 (64.9)

II

25 (14.6)

III

31 (18.1)

IV

4 (2.3)

Surgical procedures

 

TAH + BSO + OM

142 (83.0)

BSO + OM

6 (3.5)

USO + OM

8 (4.7)

OM

15 (8.8)

Surgical status

 

Complete resection

146 (85.4)

Incomplete resection

25 (14.6)

Adjuvant chemotherapy

 

Yes

129 (75.4)

Paclitaxel + Carboplatin

77

Docetaxel + Carboplatin

35

Irinotecan + Cisplatin

12

Gemcitabine + Carboplatin

1

Not available

4

No

42 (24.6)

Recurrence

 

Yes

44 (25.7)

No

127 (74.3)

Death

 

Yes

32 (18.7)

No

139 (81.3)

  1. Abbreviations: OCCC, ovarian cell carcinoma; FIGO, International Federation of Obstetrics and Gynecology; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; OM, omentectomy; USO, unilateral salpingo-oophorectomy